Blackstone’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$220K Buy
+11,037
New +$235K ﹤0.01% 375
2020
Q3
– Sell
-20,000
Closed -$851K – 190
2020
Q2
$851K Buy
+20,000
New +$781K ﹤0.01% 138

Other funds holding LEGN

Blackstone's LEGN Position: Q3 2026 in Review

Blackstone opened a new position in Legend Biotech (LEGN) in Q3 2026: 11,037 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #375 among its holdings. This is a return to the name: Blackstone previously reported a position in LEGN as recently as Q2 2020.

Blackstone first reported a position in LEGN in Q2 2020 and has held it in 2 quarters since. The position peaked at $851K in Q2 2020. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Blackstone held 11,037 shares of Legend Biotech worth $220K as of Q3 2026.
  • Legend Biotech was a new Blackstone position in Q3 2026.
  • Legend Biotech made up ﹤0.01% of Blackstone's portfolio in Q3 2026, its #375 holding.
  • Blackstone first reported a position in Legend Biotech in Q2 2020 and has held it in 2 quarters since.
  • Blackstone's Legend Biotech position peaked at $851K in Q2 2020.
  • 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Blackstone's 13F filing for Q3 2026, filed 16 Nov 2026.